Whaley Glenn Insider Trading Activity (IMUX)

Summary

Updated Jul 16, 2026

Whaley Glenn has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $32K.

Profile

Glenn Whaley is the Chief Financial Officer of Immunic Inc, a clinical-stage biopharmaceutical company focused on developing therapies for chronic inflammatory and autoimmune diseases. He has been involved in the financial management of the company as it advances its pipeline of immunology therapies.

Role	Chief Financial Officer
Notability	20/100

Board memberships

Immunic Inc

Awards & honors

Chief Financial Officer at Immunic Inc
Involved in the financial strategy of a clinical-stage biopharmaceutical company

Date	Ticker	Company	Code	Shares	Price	Value
2025-06-03	IMUX	IMMUNIC, INC.	P — Open-market purchase	45.0K	$0.71	$32K
2025-06-03	IMUX	IMMUNIC, INC.	A — Grant or award	25.0K	$0.56	$14K

Frequently Asked Questions

Who is Whaley Glenn?

How many SEC Form 4 filings has Whaley Glenn submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Whaley Glenn been buying or selling stock?

Recorded transactions: 1 open-market purchases ($32K) and 0 open-market sales () across all tracked filings.

Where can I see all of Whaley Glenn's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Whaley Glenn — SEC Form 4 Insider Trading Activity